Loading...
XSHG
603077
Market cap2.69bUSD
Dec 05, Last price  
2.36CNY
1D
2.61%
1Q
22.28%
Jan 2017
1.41%
IPO
95.31%
Name

Sichuan Hebang Biotechnology Co Ltd

Chart & Performance

D1W1MN
XSHG:603077 chart
P/E
604.16
P/S
2.22
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
-0.36%
Rev. gr., 5y
7.44%
Revenues
8.55b
-3.13%
844,372,6841,432,872,1501,899,970,0791,737,770,8891,602,663,9642,185,698,5722,862,644,1293,462,551,5454,737,645,9676,009,019,0925,969,100,7075,260,765,9889,867,109,12413,038,947,9868,824,107,8118,547,476,550
Net income
31m
-97.55%
44,156,190172,798,343366,276,401334,893,72364,437,347671,762,995239,865,850317,810,832517,539,883363,087,307516,853,7612,909,5423,018,470,6123,806,808,8691,283,243,89331,464,685
CFO
468m
+133.08%
68,967,587330,766,072552,563,091134,959,7610204,674,407449,197,351575,257,187176,944,298944,392,173162,920,484368,854,1553,196,718,0232,644,262,791200,759,143467,931,387
Dividend
Jun 07, 20230.045 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company also provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging materials and products, as well as photovoltaic glass and module products. In addition, it engages in the supply of oil and gas. The company was formerly known as SichuanHebang Biotechnology Co.,Ltd. and changed its name to Sichuan Hebang Biotechnology Corporation Limited in April 2021. Sichuan Hebang Biotechnology Corporation Limited was founded in 2002 and is based in Chengdu, China.
URL
https://www.hebang.cn/
IPO date
Jul 31, 2012
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT